Thomas Schinecker
Chief Executive Officer at ROCHE HOLDING AG
Net worth: 701 826 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Severin Schwan | M | 57 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 16 years |
Sean Johnston | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Richard P. Lifton | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 9 years |
Alan Hippe | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
Joerg Duschmale | M | 40 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 4 years |
Albert Bourla | M | 62 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Levi Garraway | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
Hans Clevers | M | 67 | 5 years | |
Akiko Iwasaki | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Aviv Regev | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Bernard Poussot | M | 72 | 9 years | |
Anita Hauser | F | 55 | 7 years | |
André S. Hoffmann | M | 66 | 28 years | |
Patrick Frost | M | 56 | 4 years | |
Claudia Dyckerhoff | M | 58 | 8 years | |
Claudia Boeckstiegel | F | 60 | 4 years | |
Andrea Grebe | M | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | 7 years |
Detlev Corsepius | M | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | - |
Axel Radlach Pries | M | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | 7 years |
Jemilah Mahmood | M | - | - | |
Astrid Lurati | F | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | 7 years |
Antonio Esteve Cruella | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Nina Beikert | F | - |
Labor Berlin - Charité Vivantes GmbH
Labor Berlin - Charité Vivantes GmbH Medical SpecialtiesHealth Technology Labor Berlin - Charité Vivantes GmbH is Europe's largest hospital laboratory located in Berlin, Germany. The German company has state-of-the-art facilities in 13 hospitals across the city and over 600 employees who work to ensure that each patient receives a diagnosis every day of the year. Labor is responsible for the diagnostics of approximately 85 percent of patient beds in Berlin. The private company's extensive network transports over 18,000 samples daily, and its employees are passionate about the well-being of the patient, striving for quality and innovation. Labor is a pioneer in future key technologies and a perfect partner for the diagnostic industry. The CEO of the company is Nina Beikert. | - |
Annette Luther | M | 54 | 4 years | |
Tim Brown | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Pascale Schmidt | F | 51 | 4 years | |
Richard Locksley | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Peggy Han | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Quita Highsmith | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Cori Davis | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 2 years |
Teresa Graham | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Silke Hörnstein | F | 49 | 9 years | |
Ed Harrington | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
Birgit Masjost | M | - | - | |
Cristina A. Wilbur | F | 57 | - | |
Bruno Eschli | M | - | - | |
Ian Read | M | 71 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Stefan Oschmann | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Hans Jörg Reinhardt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 14 years |
Ulf Mark Schneider | M | 59 | - | |
Olivier Brandicourt | M | 68 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Lana Dubovik | F | - |
New York University
| 22 years |
Tapan Durgadas Ray | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Jorge Gallardo Ballart | M | 82 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 20 years |
Paola Ricci | F | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Sabine Borngräber | F | - | - | |
Ugo di Francesco | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Nicolas Dunant | M | - | - | |
Sunao Manabe | M | 69 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 1 years |
Roger Connor | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Barbara Schadler | F | 62 | 5 years | |
Max Starkov | M | - |
New York University
| 23 years |
Ulf Arne Wiinberg | M | 66 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Dieter Weinand | M | 63 |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | - |
Beatrice Hau | F | - | - | |
Ashley Magargee | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Andreas Oeri | M | 75 | 24 years | |
Erich Hunziker | M | 70 | 10 years | |
Lodewijk J. R. de Vink | M | 78 | 9 years | |
Walter Frey | M | 80 | 10 years | |
Cheryl Mills | F | 59 |
New York University
| 7 years |
John Bell | M | 71 | 19 years | |
DeAnne Shirley Julius | M | 75 | 14 years | |
William Burns | M | 76 | 4 years | |
Domenico Scala | M | 59 | 8 years | |
Pamela Kaufman | F | - |
New York University
| 4 years |
Julie Brown | F | 62 | 6 years | |
John Beczak | M | - |
New York University
| 3 years |
Dora Lee | F | - |
New York University
| 6 years |
Beatrice Weder di Mauro | M | 57 | 10 years | |
Thomas Cueni | M | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | 7 years |
Ajar Ashyrkulova | M | - |
New York University
| 5 years |
Bob Silverman | M | - | 27 years | |
Young Min Ban | M | - |
New York University
| 4 years |
Paul Bulcke | M | 69 | 11 years | |
Fritz Gerber | M | 95 | - | |
Bruno Gehrig | M | 77 | 9 years | |
Wolfgang Ruttenstorfer | M | 73 | 4 years | |
Christoph Franz | M | 64 | 12 years | |
Pius Baschera | M | 73 | 10 years | |
Kristine F. Treglia | F | - |
New York University
| 5 years |
Peter Voser | M | 64 | 8 years | |
Gottlieb A. Keller | M | 70 | 28 years | |
Arthur Levinson | M | 73 | - | |
Tim Oshea | M | - |
New York University
| 4 years |
Chase Cho | M | - |
New York University
| 7 years |
Matthew Epstein | M | - |
New York University
| 4 years |
May Gando | F | - |
New York University
| 4 years |
Christopher Burger | M | - |
New York University
| 4 years |
Manish Rajguru | M | - |
New York University
| 2 years |
Jodi Kovitz | F | - |
New York University
| 3 years |
Alyssa Klapper | F | - |
New York University
| 1 years |
Daniel Roever | M | - |
New York University
| 2 years |
Ke Lu | M | 48 |
New York University
| 1 years |
Kirsta Anderson | F | 45 |
New York University
| 4 years |
Will Griggs | M | - |
New York University
| 4 years |
david jar | M | - |
New York University
| 4 years |
Adrian Grant | M | - |
New York University
| 4 years |
Jordan Hoffner | M | 53 |
New York University
| 2 years |
Rebecca Raphael | F | - |
New York University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Switzerland | 60 | 60.00% |
United States | 40 | 40.00% |
Germany | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Schinecker
- Personal Network